Capacity to consent to research in schizophrenia: The expanding evidence base

Behavioral Sciences and the Law

Volumn 24, Issue 4, 2006, Pages 431-445

  Dunn, Laura B ^a,b  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DECISION MAKING; DEPRESSION; ETHICS; EVIDENCE BASED PRACTICE; HUMAN; MEDICAL RESEARCH; NEUROPSYCHIATRY; PERCEPTION; PREVALENCE; PSYCHOLOGIC ASSESSMENT; SCHIZOPHRENIA; SCORING SYSTEM;

BIOMEDICAL RESEARCH; COGNITION DISORDERS; DECISION MAKING; HUMANS; INFORMED CONSENT; MENTAL COMPETENCY; SCHIZOPHRENIA; UNITED STATES;

EID: 33748319337     PISSN: 07353936     EISSN: 10990798     Source Type: Journal    
DOI: 10.1002/bsl.698     Document Type: Conference Paper

References (86)

1. Advisory Committee on Human Radiation Experiments. (1996). The human radiation experiments. New York, NY: Oxford University Press.
2. Appelbaum, P. S., & Grisso, T. (1995). The MacArthur Treatment Competence Study. I: Mental illness and competence to consent to treatment. Law and Human Behavior, 19, 105-126.
3. Appelbaum, P. S., & Grisso, T. (2001). MacCAT-CR: MacArthur Competence Assessment Tool for Clinical Research. Sarasota, FL: Professional Resource Press.
4. Appelbaum, P. S., Grisso, T., Frank, E., O'Donnell, S., & Kupfer, D. J. (1999). Competence of depressed patients for consent to research. American Journal of Psychiatry, 156, 1380-1384.
5. Appelbaum, P. S., Lidz, C. W., & Grisso, T. (2004). Therapeutic misconception in clinical research: Frequency and risk factors. IRB, 26, 1-8.
6. Appelbaum, P. S., Roth, L. H., & Lidz, C. (1982). The therapeutic misconception: Informed consent in psychiatric research. International Journal of Law and Psychiatry, 5, 319-329.
7. Appelbaum, P. S., Roth, L. H., Lidz, C. W., Benson, P., & Winslade, W. (1987). False hopes and best data: Consent to research and the therapeutic misconception. The Hastings Center Report, 17, 20-24.
8. Biesecker, B. B., & Peay, H. L. (2003). Ethical issues in psychiatric genetics research: Points to consider. Psychopharmacology, 171, 27-35.
9. Carpenter, W. T., Appelbaum, P. S., & Levine, R. J. (2003). The Declaration of Helsinki and clinical trials: A focus on placebo-controlled trials in schizophrenia. American Journal of Psychiatry, 160, 356-362.
10. Carpenter, W. T., & Conley, R. R. (1999). Sense and nonsense: An essay on schizophrenia research ethics. Schizophrenia Research, 35, 219-225; discussion 227-236.
11. Carpenter, W. T., Gold, J. M., Lahti, A. C., Queern, C. A., Conley, R. R., Bartko, J. J., et al. (2000). Decisional capacity for informed consent in schizophrenia research. Archives of General Psychiatry, 57, 533-538.
12. Carpenter, W. T., Schooler, N. R., & Kane, J. M. (1997). The rationale and ethics of medication-free research in schizophrenia. Archives of General Psychiatry, 54, 401-407.
13. Centerwatch.com. Clinical trials in psychiatry/psychology. Retrieved May 30, 2005, from http://www.centerwatch.com/patient/studies/area17.html
14. Clinicaltrials.gov. Retrieved May 30, 2005, from http://www. clinicaltrials.gov
15. Corcoran, C., Malaspina, D., & Hercher, L. (2005). Prodromal interventions for schizophrenia vulnerability: The risks of being "at risk". Schizophrenia Research, 73, 173-184.
16. Daugherty, C., Ratain, M. J., Grochowski, E., Stocking, C., Kodish, E., Mick, R., et al. (1995). Perceptions of cancer patients and their physicians involved in phase I trials. Journal of Clinical Oncology, 13, 1062-1072.
17. Dresser, R. (2002). The ubiquity and utility of the therapeutic misconception. Social Philosophy and Policy, 19, 271-294.
18. Dunn, L. B., & Jeste, D. V. (2001). Enhancing informed consent for research and treatment. Neuropsychopharmacology, 24, 595-607.
19. Dunn, L. B., & Jeste, D. V. (2003). Problem areas in the understanding of informed consent for research: Study of middle-aged and older patients with psychotic disorders. Psychopharmacology, 171, 81-85.
20. Dunn, L. B., Lindamer, L. A., Palmer, B. W., Golshan, S., Schneiderman, L. J., & Jeste, D. V. (2002). Improving understanding of research consent in middle-aged and elderly patients with psychotic disorders. American Journal of Geriatric Psychiatry, 10, 142-150.
21. Dunn, L. B., Lindamer, L. A., Palmer, B. W., Schneiderman, L. J., & Jeste, D. V. (2001). Enhancing comprehension of consent for research in older patients with psychosis: A randomized study of a novel consent procedure. American Journal of Psychiatry, 158, 1911-1913.
22. Dunn, L. B., Nowrangi, M., Palmer, B. W., Jeste, D. V., & Saks, E. (in press-a). Assessing capacity to consent to treatment and research: A review of instruments. American Journal of Psychiatry.
23. Dunn, L., Palmer, B. W., Keehan, M., Jeste, D. V., & Appelbaum, P. (2006). Assessment of therapeutic misconception in older schizophrenia patients using a brief instrument. American Journal of Psychiatry.
24. Dunn, L. B., & Roberts, L. W. (2005). Emerging findings in ethics of schizophrenia research. Current Opinion in Psychiatry, 18, 111-119.
25. Emanuel, E. J., Wendler, D., & Grady, C. (2000). What makes clinical research ethical? Journal of the American Medical Association, 283, 2701-2711.
26. Faden, R., Beauchamp, T., & King, N. (1986). A history and theory of informed consent. New York: Oxford University Press.
27. Fleischhacker, W. W., Czobor, P., Hummer, M., Kemmler, G., Kohnen, R., & Volavka, J. (2003). Placebo or active control trials of antipsychotic drugs? Archives of General Psychiatry, 60, 458-464.
28. Flory, J., & Emanuel, E. (2004). Interventions to improve research participants' understanding in informed consent for research: A systematic review. Journal of the American Medical Association, 292, 1593-1601.
29. Grisso, T. (2003). Evaluating competencies: Forensic assessments and instruments (2nd ed.). New York: Kluwer.
30. Grisso, T., & Appelbaum, P. S. (1995a). Comparison of standards for assessing patients' capacities to make treatment decisions. American Journal of Psychiatry, 152, 1033-1037.
31. Grisso, T., & Appelbaum, P. S. (1995b). The MacArthur Treatment Competence Study. III: Abilities of patients to consent to psychiatric and medical treatments. Law and Human Behavior, 19, 149-174.
32. Grisso, T., & Appelbaum, P. (1998). Assessing competence to consent to treatment: A guide for physicians and other health professionals. New York: Oxford University Press.
33. Grisso, T., Appelbaum, P. S., & Hill-Fotouhi, C. (1997). The MacCAT-T: A clinical tool to assess patients' capacities to make treatment decisions. Psychiatric Services, 48, 1415-1419.
34. Grisso, T., Appelbaum, P. S., Mulvey, E. P., & Fletcher, K. (1995). The MacArthur Treatment Competence Study. II: Measures of abilities related to competence to consent to treatment. Law and Human Behavior, 19, 127-148.
35. Hougham, G. W., Sachs, G. A., Danner, D., Mintz, J., Patterson, M., Roberts, L. W., et al. (2003). Empirical research on informed consent with the cognitively impaired. IRB, Supplement 25, S26-S32.
36. Hyman, S. E. (1999). Protecting patients, preserving progress: Ethics in mental health illness research. Academic Medicine, 74, 258-259.
37. Joffe, S., Cook, E. F., Cleary, P. D., Clark, J. W., & Weeks, J. C. (2001a). Quality of informed consent in cancer clinical trials: A cross-sectional survey. Lancet, 358, 1772-1777.
38. Joffe, S., Cook, E. F., Cleary, P. D., Clark, J. W., & Weeks, J. C. (2001b). Quality of informed consent: A new measure of understanding among research subjects. Journal of the National Cancer Institute, 93, 139-147.
39. Karlawish, J. H., Casarett, D. J., & James, B. D. (2002). Alzheimer's disease patients' and caregivers' capacity, competency, and reasons to enroll in an early-phase Alzheimer's disease clinical trial. Journal of the American Geriatrics Society, 50, 2019-2024.
40. Kim, S. Y. (2003). Benefits and burdens of placebos in psychiatric research. Psychopharmacology, 171, 13-18.
41. Kim, S. Y., & Caine, E. D. (2002). Utility and limits of the Mini-Mental State Examination in evaluating consent capacity in Alzheimer's disease. Psychiatric Services, 53, 1322-1324.
42. Kim, S. Y., Caine, E. D., Currier, G. W., Leibovici, A., & Ryan, J. M. (2001). Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research. American Journal of Psychiatry, 158, 712-717.
43. King, N., Henderson, G. E., Churchill, L. R., Davis, A. M., Hull, S., Nelson, D. K., et al. (2005). Consent forms and the therapeutic misconception: the example of gene transfer research. IRB, 27. 1-8.
44. Kovnick, J. A., Appelbaum, P. S., Hoge, S. K., & Leadbetter, R. A. (2003). Competence to consent to research among long-stay inpatients with chronic schizophrenia. Psychiatric Services, 54, 1247-1252.
45. Lavori, P. W., Sugarman, J., Hays, M. T., & Feussner, J. R. (1999). Improving informed consent in clinical trials: A duty to experiment. Controlled Clinical Trials, 20, 187-193.
46. Lidz, C. W., & Appelbaum, P. S. (2002). The therapeutic misconception: Problems and solutions. Medical Care, 40, V55-V63.
47. Lidz, C. W., Appelbaum, P. S., Grisso, T., & Renaud, M. (2004). Therapeutic misconception and the appreciation of risks in clinical trials. Social Science and Medicine, 58, 1689-1697.
48. Lidz, C. W., Appelbaum, P. S., & Meisel, A. (1988). Two models of implementing informed consent. Archives of Internal Medicine, 148, 1385-1389.
49. Llewellyn-Thomas, H. A., McGreal, M. J., Thiel, E. C., Fine, S., & Erlichman, C. (1991). Patients' willingness to enter clinical trials: Measuring the association with perceived benefit and preference for decision participation. Social Science and Medicine, 32, 35-42.
50. Marson, D. C., Chatterjee, A., Ingram, K. K., & Harrell, L. E. (1996). Toward a neurologic model of competency: Cognitive predictors of capacity to consent in Alzheimer's disease using three different legal standards. Neurology, 46, 666-672.
51. Marson, D. C., Cody, H. A., Ingram, K. K., & Harrell, L. E. (1995a). Neuropsychologic predictors of competency in Alzheimer's disease using a rational reasons legal standard. Archives of Neurology, 52, 955-959.
52. Marson, D., & Harrell, L. (1999). Executive dysfunction and loss of capacity to consent to medical treatment in patients with Alzheimer's disease. Seminars in Clinical Neuropsychiatry, 4, 41-49.
53. Marson, D. C., Ingram, K. K., Cody, H. A., & Harrell, L. E. (1995b). Assessing the competency of patients with Alzheimer's disease under different legal standards. A prototype instrument. Archives of Neurology, 52, 949-954.
54. Michels, R. (1999). Are research ethics bad for our mental health? New England Journal of Medicine, 340, 1427-1430.
55. Miller. F. G. (2000). Placebo-controlled trials in psychiatric research: An ethical perspective. Biological Psychiatry, 47, 707-716.
56. Miller, F. G. (2002). Ethical significance of ethics-related empirical research. Journal of the National Cancer Institute, 94, 1821-1822.
57. Miller, F. G., & Brody, H. (2003). A critique of clinical equipoise. Therapeutic misconception in the ethics of clinical trials. Hastings Center Report, 33, 19-28.
58. Miller, F. G., & Fins, J. J. (1999). Protecting vulnerable research subjects without unduly constraining neuropsychiatric research. Archives of General Psychiatry, 56, 701-702; discussion 703-704.
59. Moser, D., Reese, R., Schultz, S., Benjamin, M., Arndt, S., Fleming, F., et al. (2005). Informed consent in medication-free schizophrenia research. American Journal of Psychiatry, 162, 1209-1211.
60. Moser, D. J., Schultz, S. K., Arndt, S., Benjamin, M. L., Fleming, F. W., Brems, C. S., et al. (2002). Capacity to provide informed consent for participation in schizophrenia and HIV research. American Journal of Psychiatry:, 159, 1201-1207.
61. National Bioethics Advisory Commission. (1998). Research involving persons with mental disorders that may affect decisionmaking capacity. Rockville, MD: Author.
62. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. (1978). The Belmont Report (DHEW Publ. No. OS-78-0012). Washington, DC: U.S. Government Printing Office.
63. National Institute of Mental Health. (2005). Strategic plans and priorities. Retrieved June 8, 2005, from http://www.nimh.nih.gov/strategic/ strategicplanmenu.cfm
64. Oldham, J. M., Haimowitz, S., & Delano, S. J. (1999). Protection of persons with mental disorders from research risk: A response to the report of the National Bioethics Advisory Commission. Archives of General Psychiatry, 56, 688-693.
65. Palmer, B. W., Dunn, L. B., Appelbaum, P. S., & Jeste, D. V. (2004). Correlates of treatment-related decision-making capacity among middle-aged and older patients with schizophrenia. Archives of General Psychiatry, 61, 230-236.
66. Palmer, B. W., Dunn, L. B., Appelbaum, P. S., Mudaliar, S., Thai, L., Henry, R., et al. (2005). Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease or diabetes mellitus: Comparison of a three-item questionnaire with a comprehensive standardized capacity instrument. Archives of General Psychiatry, 62, 726-733.
67. Palmer, B. W., Heaton, R. K., Paulsen, J. S., Kuck, J., Braff, D., Harris, M. J., et al. (1997). Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology, 11, 437-446.
68. Penman, D. T., Holland, J. C., Bahna, G. F., Morrow, G., Schmale, A. H., Derogatis, L. R., et al. (1984). Informed consent for investigational chemotherapy: Patients' and physicians' perceptions. Journal of Clinical Oncology, 2, 849-855.
69. Pincus, H., Lieberman, J., & Ferris, S. (1999). Ethics in psychiatric research: A resource manual for human subjects protection. Washington, DC: American Psychiatric Association.
70. Prentice, K. J., Gold, J. M., & Carpenter, W. T. (2005). Optimistic bias in the perception of personal risk: Patterns in schizophrenia. American Journal of Psychiatry, 162, 507-512.
71. Roberts, L. W. (2002a). Ethics and mental illness research. Psychiatric Clinics of North America, 25, 525-545.
72. Roberts, L. W. (2002b). Informed consent and the capacity for voluntarism. American Journal of Psychiatry, 159, 705-712.
73. Roberts, L. W., Geppert, C. M., & Brody, J. L. (2001). A framework for considering the ethical aspects of psychiatric research protocols. Comprehensive Psychiatry, 42, 351-363.
74. Roberts, L., & Roberts, B. (1999). Psychiatric research ethics: An overview of evolving guidelines and current ethical dilemmas in the study of mental illness. Biological Psychiatry, 46, 1025-1038.
75. Roberts, L. W., Warner, T. D., Brody, J. L., Roberts, B., Lauriello, J., & Lyketsos, C. (2002). Patient and psychiatrist ratings of hypothetical schizophrenia research protocols: assessment of harm potential and factors influencing participation decisions. American Journal of Psychiatry, 159, 573-584.
76. Rodenhuis, S., van den Heuvel, W. J., Annyas, A. A., Koops, H. S., Sleijfer, D. T., & Mulder, N. H. (1984). Patient motivation and informed consent in a phase I study of an anticancer agent. European Journal of Cancer and Clinical Oncology, 20, 457-462.
77. Rosenstein, D. L., & Miller, F. G. (2003). Ethical considerations in psychopharmacological research involving decisionally impaired subjects. Psychopharmacology, 171, 92-97.
78. Roth, L. H., Meisel, A., & Lidz, C. W. (1977). Tests of competency to consent to treatment. American Journal of Psychiatry, 134, 279-284.
79. Sachs, G. A., Hougham, G. W., Sugarman, J., Agre, P., Broome, M. E., Geller, G., et al. (2003). Conducting empirical research on informed consent: Challenges and questions. IRB, Supplement 25, S4-S10.
80. Stiles, P. G., Poythress, N. G., Hall, A., Falkenbach, D., & Williams, R. (2001). Improving understanding of research consent disclosures among persons with mental illness. Psychiatric Services, 52, 780-785.
81. Sugarman, J., McCrory, D. C., & Hubal, R. C. (1998). Getting meaningful informed consent from older adults: A structured literature review of empirical research. Journal of the American Geriatrics Society, 46, 517-524.
82. Sugarman, J., McCrory, D. C., Powell, D., Krasny, A., Adams, B., Ball, E., et al. (1999). Empirical research on informed consent. An annotated bibliography. Hastings Center Report, 29, S1-42.
83. Weijer, C. (1999). Placebo-controlled trials in schizophrenia: Are they ethical? Are they necessary? Schizophrenia Research, 35, 211-218; discussion 227-236.
84. Wendler, D. (2004). Can we ensure that all research subjects give valid consent? Archives of Internal Medicine, 164, 2201-2204.
85. Wirshing, D. A., Sergi, M. J., & Mintz, J. (2005). A videotape intervention to enhance the informed consent process for medical and psychiatric treatment research. American Journal of Psychiatry, 162, 186-188.
86. Wirshing, D. A., Wirshing, W. C., Marder, S. R., Liberman, R. P., & Mintz, J. (1998). Informed consent: assessment of comprehension. American Journal of Psychiatry, 155, 1508-1511.